TRCT
ULBI icon

Tower Research Capital (TRC)’s Ultralife ULBI Stock Holding History

Tower Research Capital (TRC)’s Portfolio ULBI Stock Details ULBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-690
Closed -$3.95K – 5579
2025
Q4 		$3.95K Sell
690
-508
-42% -$3.13K ﹤0.01% 4287
2025
Q3 		$8.17K Sell
1,198
-2,081
-63% -$15.8K ﹤0.01% 4060
2025
Q2 		$29.4K Buy
3,279
+1,023
+45% +$6.06K ﹤0.01% 3412
2025
Q1 		$12.1K Buy
2,256
+904
+67% +$6.14K ﹤0.01% 3464
2024
Q4 		$10.1K Sell
1,352
-568
-30% -$4.67K ﹤0.01% 3847
2024
Q3 		$17.4K Buy
1,920
+1,434
+295% +$14.8K ﹤0.01% 3321
2024
Q2 		$5.16K Sell
486
-1,357
-74% -$14.4K ﹤0.01% 4711
2024
Q1 		$16.2K Sell
1,843
-820
-31% -$6.67K ﹤0.01% 3199
2023
Q4 		$18.2K Buy
2,663
+2,563
+2,563% +$21K ﹤0.01% 3710
2023
Q3 		$976 Sell
100
-6,215
-98% -$49.8K ﹤0.01% 5439
2023
Q2 		$30.6K Sell
6,315
-1,700
-21% -$7.39K ﹤0.01% 3012
2023
Q1 		$32K Buy
8,015
+1,322
+20% +$5.31K ﹤0.01% 2937
2022
Q4 		$26K Buy
6,693
+1,737
+35% +$8.01K ﹤0.01% 2893
2022
Q3 		$24K Sell
4,956
-2,490
-33% -$11.8K ﹤0.01% 3796
2022
Q2 		$34K Buy
7,446
+5,410
+266% +$26.6K ﹤0.01% 3259
2022
Q1 		$11K Buy
2,036
+1,536
+307% +$8.22K ﹤0.01% 4220
2021
Q4 		$3K Buy
+500
New +$3.07K ﹤0.01% 5502
2021
Q3 		– Sell
-5,421
Closed -$45K – 6191
2021
Q2 		$45K Buy
5,421
+3,478
+179% +$29.9K ﹤0.01% 3111
2021
Q1 		$16K Sell
1,943
-701
-27% -$4.97K ﹤0.01% 4068
2020
Q4 		$17K Sell
2,644
-6,598
-71% -$41.6K ﹤0.01% 3979
2020
Q3 		$54K Sell
9,242
-5,696
-38% -$37.4K ﹤0.01% 3508
2020
Q2 		$105K Buy
14,938
+14,421
+2,789% +$105K ﹤0.01% 2414
2020
Q1 		$3K Sell
517
-272
-34% -$1.86K ﹤0.01% 2501
2019
Q4 		$6K Buy
789
+268
+51% +$2.22K ﹤0.01% 2620
2019
Q3 		$4K Buy
521
+165
+46% +$1.41K ﹤0.01% 3466
2019
Q2 		$3K Sell
356
-6,377
-95% -$58K ﹤0.01% 3168
2019
Q1 		$70K Buy
6,733
+1,469
+28% +$13.2K ﹤0.01% 1605
2018
Q4 		$36K Buy
5,264
+4,147
+371% +$30.1K ﹤0.01% 1513
2018
Q3 		$9K Sell
1,117
-6,324
-85% -$59.1K ﹤0.01% 2838
2018
Q2 		$71K Buy
+7,441
New +$71.3K ﹤0.01% 1652
2018
Q1 		– Sell
-1,434
Closed -$9K – 3852
2017
Q4 		$9K Sell
1,434
-659
-31% -$4.42K ﹤0.01% 2626
2017
Q3 		$14K Buy
2,093
+804
+62% +$5.48K ﹤0.01% 2924
2017
Q2 		$9K Sell
1,289
-1,629
-56% -$9.97K ﹤0.01% 1675
2017
Q1 		$16K Buy
2,918
+2,062
+241% +$11.2K ﹤0.01% 1450
2016
Q4 		$4K Sell
856
-7,557
-90% -$33.9K ﹤0.01% 3169
2016
Q3 		$35K Buy
8,413
+3,934
+88% +$17.3K ﹤0.01% 1332
2016
Q2 		$22K Buy
4,479
+4,263
+1,974% +$20.2K ﹤0.01% 2166
2016
Q1 		$1K Sell
216
-155
-42% -$840 ﹤0.01% 3793
2015
Q4 		$2K Buy
+371
New +$2.45K ﹤0.01% 3816
2015
Q3 		– Sell
-1,529
Closed -$7K – 4787
2015
Q2 		$7K Buy
1,529
+1,010
+195% +$4.11K ﹤0.01% 3013
2015
Q1 		$2K Sell
519
-33
-6% -$114 ﹤0.01% 3833
2014
Q4 		$1K Sell
552
-560
-50% -$1.72K ﹤0.01% 3730
2014
Q3 		$4K Buy
1,112
+983
+762% +$3.38K ﹤0.01% 3466
2014
Q2 		$0 Buy
129
+61
+90% +$234 ﹤0.01% 4661
2014
Q1 		$0 Sell
68
-2,869
-98% -$11K ﹤0.01% 4948
2013
Q4 		$10K Buy
2,937
+1,563
+114% +$5.84K ﹤0.01% 3004
2013
Q3 		$6K Sell
1,374
-3,739
-73% -$14.1K ﹤0.01% 3571
2013
Q2 		$18K Buy
+5,113
New +$19.9K ﹤0.01% 1827

Other funds holding ULBI

VWA
Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
THC
Truffle Hound Capital Bethesda, Maryland $386M AUM 57.88% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Tower Research Capital (TRC)'s ULBI Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of Ultralife (ULBI) in Q1 2026, closing a stake of 690 shares — an estimated $3.95K sold.

Tower Research Capital (TRC) first reported a position in ULBI in Q2 2013 and held it in 48 quarters. The position peaked at $105K in Q2 2020. 50 funds tracked by Wall St. Rank hold ULBI as of Q1 2026.

  • Tower Research Capital (TRC) reported no remaining Ultralife position as of Q1 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 690 Ultralife shares in Q1 2026, an estimated $3.95K.
  • Tower Research Capital (TRC) first reported a position in Ultralife in Q2 2013 and held it in 48 quarters.
  • Tower Research Capital (TRC)'s Ultralife position peaked at $105K in Q2 2020.
  • 50 funds tracked by Wall St. Rank held Ultralife as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.